+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Jardiance"

From
From
From
From
From
From
From
From
From
From
From
From
Jardiance - Product Thumbnail Image

Jardiance

  • Drug Pipelines
  • February 2019
  • 43 Pages
  • Global
From
Drug Analysis: Diabetic Nephropathy Market and Forecast Analyst to 2025 - Product Thumbnail Image

Drug Analysis: Diabetic Nephropathy Market and Forecast Analyst to 2025

  • Drug Pipelines
  • February 2018
  • 207 Pages
  • Global
From
Disease Analysis: Diabetic Nephropathy - Product Thumbnail Image

Disease Analysis: Diabetic Nephropathy

  • Report
  • February 2021
  • 90 Pages
  • Global
Jardiance - API Insight, 2022 - Product Thumbnail Image

Jardiance - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Jardiance- Drug Insight, 2019 - Product Thumbnail Image

Jardiance- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Loading Indicator

Jardiance is a medication used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which work by blocking the reabsorption of glucose in the kidneys, allowing it to be excreted in the urine. This helps to lower blood sugar levels. Jardiance is typically used in combination with other diabetes medications, such as metformin, to help control blood sugar levels. Jardiance is part of a larger market of endocrine and metabolic disorder drugs, which includes medications used to treat conditions such as obesity, thyroid disorders, and polycystic ovary syndrome. These drugs are used to help regulate hormones and metabolism, and can help to improve overall health and quality of life. Companies in the Jardiance market include Boehringer Ingelheim, Merck, and Eli Lilly. Show Less Read more